In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species

about

INK128 Exhibits Synergy with Azoles against Exophiala spp. and Fusarium spp.

P2860

Q37351952-7DA6E913-8BE0-4B90-92BC-45B97B30F40C

P2860

In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species

Item

http://www.wikidata.org/entity/Q36933432

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

In Vitro Interactions between ...... ts against Aspergillus Species

@en

type

Item

label

In Vitro Interactions between ...... ts against Aspergillus Species

@en

prefLabel

In Vitro Interactions between ...... ts against Aspergillus Species

@en

P1476

In Vitro Interactions between ...... ts against Aspergillus Species

@en

P2093

Lujuan Gao

http://www.w3.org/2001/XMLSchema#string

Qingzhi Wu

http://www.w3.org/2001/XMLSchema#string

Tongxiang Zeng

http://www.w3.org/2001/XMLSchema#string

Xiaozhen Ding

http://www.w3.org/2001/XMLSchema#string

Yi Sun

http://www.w3.org/2001/XMLSchema#string

Zhun Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.

Polyphasic taxonomy of Aspergillus fumigatus and related species.

What is a species in Aspergillus?

Invasive aspergillosis in 2002: an update.

Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).

Nutrient signaling through TOR kinases controls gene expression and cellular differentiation in fungi.

Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice.

The translational landscape of mTOR signalling steers cancer initiation and metastasis

In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models.

P304

3813-3816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02921-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26976874

http://www.w3.org/2001/XMLSchema#string

P932

4879397

http://www.w3.org/2001/XMLSchema#string

In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species

about

P2860

P2860

In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932